Premature sebaceous gland hyperplasia

Villez, Richard L. De; Roberts, L.

doi:10.1016/s0190-9622(82)80128-x

Cited by 31 publications

(13 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…4,8 Although the condition is referred to as ìsenile sebaceous hyperplasiaî, it may also occur in young people. [9][10][11] Diagnosis is generally clinical and can be confirmed by histopathology. Dermoscopy and confocal microscopy may be useful in the clinical evaluation of the patient, principally to differentiate in vivo between sebaceous hyperplasia and basal cell carcinoma, its principal differential diagnosis.…”

Section: Introductionmentioning

confidence: 99%

Hiperplasia sebácea cutânea: estudo piloto para a correlação da doença com hormônios androgênios

Tagliolatto¹,

Alchorne

Enokihara

2011

An. Bras. Dermatol.

View full text Add to dashboard Cite

FUNDAMENTOS: As glândulas sebáceas são suscetíveis à ação dos hormônios androgênios e apresentam proliferação benigna com a idade, ou seja, hiperplasia. OBJETIVOS: Estudo piloto para verificar se há correlação entre a taxa de hormônios masculinos circulantes e o aumento da incidência da hiperplasia das glândulas sebáceas. MÉTODOS: 16 pacientes do sexo feminino, com diagnóstico de hiperplasia sebácea cutânea, foram comparados a um grupo-controle de mesmo gênero e idades semelhantes, sem a doença. Ambos os grupos foram submetidos a testes de dosagem sanguínea para avaliação das taxas de hormônios androgênios circulantes (testosterona livre e total, androstenediona). Os resultados foram tabulados e analisados estatisticamente. RESULTADOS: Os dados demonstraram não haver mudanças nos níveis de hormônios masculinos circulantes dos pacientes com hiperplasia sebácea cutânea, quando comparados ao grupo-controle. CONCLUSÃO: Os dados sugerem que não há alterações estatisticamente significantes nas taxas dos hormônios circulantes (testosterona livre e total, androstenediona, deidroepiandrosterona, sulfato de deidroepiandrosterona) dos pacientes com hiperplasia sebácea cutânea.

show abstract

Section: Introductionmentioning

confidence: 99%

Hiperplasia sebácea cutânea: estudo piloto para a correlação da doença com hormônios androgênios

Tagliolatto¹,

Alchorne

Enokihara

2011

An. Bras. Dermatol.

View full text Add to dashboard Cite

show abstract

“…Moreover, the hair follicle-like struc tures seen in sebaceous trichofolliculoma [5] were not ob served in our case. As variant types of sebaceous gland hyperplasia, some cases have been reported under the title of 'premature sebaceous gland hyperplasia' [6], 'areolar sebaceous hyperplasia' [7,8], 'hyperplasia of sebaceous glands in a linear pattern of papules' [9] and 'sebaceous gland hyperplasia of the vulva' [10]. Such cases are unlike ours in location and in clinical and histological findings.…”

Section: Discussionmentioning

confidence: 98%

Giant Solitary Sebaceous Gland Hyperplasia on the Frontal Region

1990

View full text Add to dashboard Cite

show abstract

“…Five sporadic cases of premature diffuse sebaceous hyperplasia, which had the same clinical characteristics of diffuse functional papular eruptions over the face, were also reported (Table ) . However, the special distribution sparing the periorificial areas was not documented.…”

Section: Discussionmentioning

confidence: 99%

Presenile diffuse familial sebaceous hyperplasia successfully treated with low‐dose isotretinoin: A report of two cases and review of the published work

Liu

Cheng

Liu

et al. 2016

The Journal of Dermatology

View full text Add to dashboard Cite

Presenile diffuse familial sebaceous hyperplasia (PDFSH) presents as extensive yellowish papules with central umbilication on the face without involvement of periorificial regions and occurs in adolescents or young adults with a positive family history. Thirteen cases of PDFSH have been reported in the English‐language published work, 10 of which responded to oral isotretinoin from 0.5 to 1 mg/kg per day but recurrences were often observed. Herein, we report two cases of PDFSH, which were successfully managed without recurrence with prolonged low‐dose isotretinoin (0.2 mg/kg per day, a cumulative dose of 41 and 64 mg/kg, respectively). Treatment protocols among different published works were reviewed to verify the efficacy of isotretinoin.

show abstract

Premature sebaceous gland hyperplasia

Cited by 31 publications

References 5 publications

Hiperplasia sebácea cutânea: estudo piloto para a correlação da doença com hormônios androgênios

Hiperplasia sebácea cutânea: estudo piloto para a correlação da doença com hormônios androgênios

Giant Solitary Sebaceous Gland Hyperplasia on the Frontal Region

Presenile diffuse familial sebaceous hyperplasia successfully treated with low‐dose isotretinoin: A report of two cases and review of the published work

Contact Info

Product

Resources

About